Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Remogliflozin Etabonate vs Pioglitazone in Treatment Naive T2DM
NCT00500331Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of remogliflozin etabonate in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jan 2007; status: completed.
02
Drugs
remogliflozin etabonate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00500331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500331.